Evidence map›Paper›PMID 33797952›Full record

Trial reportJCO oncology practice2021

Mobile Application to Identify Cancer Treatment-Related Financial Assistance: Results of a Randomized Controlled Trial.

Aaron M Tarnasky, George N Tran, Jonathan Nicolla, Fred A P Friedman, Steven Wolf, Jesse D Troy, Anthony D Sung, Kanan Shah, Jakob Oury, Jillian C Thompson and 4 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in JCO oncology practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05527392 (Assessing the Effect of Virtual Navigation Interventions to Improve Health Insurance Literacy and Decrease Financial Burden), which is not on this map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05527392 naactive not recruitingnot on this mapstarted 2023, after this paper: background citation

Assessing the Effect of Virtual Navigation Interventions to Improve Health Insurance Literacy and Decrease Financial Burden: A Childhood Cancer Survivor Study Randomized Trial (HINTII)

TypeinterventionalSponsorMassachusetts General HospitalRan2023 to 2027Enrolled529ConditionsChildhood Cancer SurvivorsArmsHealth Insurance Navigation Tools Program
3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Trial
  2. Financial Toxicity Monitoring in a Randomized Controlled Trial of Patient-Reported Outcomes During Cancer Treatment (Alliance AFT-39).Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Lay healthcare worker financial toxicity intervention: a pilot financial toxicity screening and referral program.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Defining the Role of the Modern Oncology Provider in Mitigating Financial Toxicity.Journal of the American College of Radiology : JACR · 2023
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Aaron M TarnaskyDuke University School of Medicine, Durham, NC.ORCID 0000-0001-7801-6916
George N TranDuke University School of Medicine, Durham, NC.ORCID 0000-0002-7592-6671
Jonathan NicollaDuke Cancer Institute, Durham, NC.
Fred A P FriedmanDuke Cancer Institute, Durham, NC.ORCID 0000-0001-8113-2686
Steven WolfDepartment of Biostatistics and Bioinformatics, Duke University, Durham, NC.
Jesse D TroyDepartment of Pediatrics, Duke University, Durham, NC.ORCID 0000-0001-5410-8146
Anthony D SungDuke University School of Medicine, Durham, NC.ORCID 0000-0003-3765-641X
Kanan ShahNYU Grossman School of Medicine, New York, NY.
Jakob OuryDuke Cancer Institute, Durham, NC.
Jillian C ThompsonDuke Cancer Institute, Durham, NC.
Ben GagosianVivor, LLC, New York, NY.
Kathryn I PollakDuke University School of Medicine, Durham, NC.
Ian MannersVivor, LLC, New York, NY.
S Yousuf ZafarDuke University School of Medicine, Durham, NC.ORCID 0000-0002-9039-5258

Funding

A mobile app to reduce treatment-related financial burden for cancer patientsR42CA210699 · NCI · VIVOR, LLC · PI ZAFAR, SYED YOUSUF · 2016 to 2018
$1.7M
NCI NIH HHS R42 CA210699
6 · The paper itself

Abstract

purposeInsured patients with cancer face high treatment-related, out-of-pocket (OOP) costs and often cannot access financial assistance. We conducted a randomized, controlled trial of Bridge, a patient-facing app designed to identify eligible financial resources for patients. We hypothesized that patients using Bridge would experience greater OOP cost reduction than controls.

methodsWe enrolled patients with cancer who had OOP expenses from January 2018 to March 2019. We randomly assigned patients 1:1 to intervention (Bridge) versus control (financial assistance educational websites). Primary and secondary outcomes were self-reported OOP costs and subjective financial distress 3 months postenrollment. In

resultsWe enrolled 200 patients. The median age was 57 years (IQR, 47.0-63.0). Most patients had private insurance (71%), and the median household income was $62,000 in US dollars (USD) (IQR, $36,000-$100,000 [USD]). Substantial missing data precluded assessment of primary and secondary outcomes. In

conclusionWe were unable to test our primary outcome because of excessive missing follow-up survey data. In exploratory post hoc analyses, patients who received a financial assistance app were more likely to apply for and receive financial assistance. Ultimately, our study highlights challenges faced in identifying measurable outcomes and retaining participants in a randomized, controlled trial of a mobile app to alleviate financial toxicity.

Indexed as

Mobile ApplicationsNeoplasmsHealth ExpendituresHumansIncomeMiddle AgedSurveys and Questionnaires

Identifiers

PMID33797952
PMCPMC8791821

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.